VAT: Boehringer Ingelheim Post-Supply Payments Not Treated as Price Rebates

• The UT ruled that Boehringer Ingelheim’s payments to the NHS were not generally retrospective price reductions for VAT purposes, so output VAT could not usually be reduced.
• BIL had argued the payments were rebates tied to sales growth under voluntary schemes and claimed about £21.5m in overpaid VAT; HMRC rejected this, and the UT sided with HMRC.
• The UT said a post-supply payment counts as a price reduction only if it has a direct link to an identifiable supply, reflects reciprocal performance, and is made to an identifiable final consumer.
• Some payments met that test, but most were too remote and reflected the NHS’s special funding arrangements rather than specific supplies.
• The case matters for businesses making post-supply payments and may go to the Court of Appeal.

Source: taxand.com

Note that this post was (partially) written with the help of AI. It is always useful to review the original source material, and where needed to obtain (local) advice from a specialist.

---

---